In 1953 the first toad was cloned. Now, fifty years later, it is very hard to be prohibit what's to come, because we are facing a new, ideal medicine a la carte, which serves interchangeable body parts and intracellular therapies. Bioethics has understood the Commerce and Industry proposal, for that reason you can get a patent if you are using an artificial way to obtain an embryo, were you are not using an spermatozoa and an ovule. This is what we call Artificial embryo, Non reproductive clonation, or therapeutics clonation. In the reform proposed to the Penal Codice, in chapter V, we found a positive wave of thought about Genetic Manipulation and Body Parts Commerce, like the German thinking style, and my style.

Artificial embryo; therapeutic clonation; non reproductive clonation; penal codice reform; body parts commerce; artificial fecundation; constitutional vote 2000-02306